BRAF Mutants Evade ERK-Dependent Feedback by Different Mechanisms that Determine Their Sensitivity to Pharmacologic Inhibition

Cancer Cell
Zhan YaoN Rosen

Abstract

ERK signaling requires RAS-induced RAF dimerization and is limited by feedback. Activated BRAF mutants evade feedback inhibition of RAS by either of two mechanisms. BRAF V600 mutants are activated monomers when RAS activity is low; all other activating BRAF mutants function as constitutive RAS-independent dimers. RAF inhibitors effectively inhibit mutant monomers, but not dimers; their binding to one site in the dimer significantly reduces their affinity for the second. Tumors with non-V600E BRAF mutants are insensitive to these drugs, and increased expression of BRAF V600E dimers causes acquired resistance. A compound that equally inhibits both sites of mutant RAF dimers inhibits tumors driven by either class of mutants or those BRAF V600E tumors with dimer-dependent acquired resistance to monomer-specific inhibitors.

References

Jun 21, 1994·Proceedings of the National Academy of Sciences of the United States of America·J R FabianD K Morrison
Mar 15, 1996·The Journal of Biological Chemistry· Dong ChenJ E Pessin
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·R E CutlerD K Morrison
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Mar 24, 2004·Cell·Paul T C WanUNKNOWN Cancer Genome Project
Jan 25, 2005·Molecular Cell·Michele K DoughertyDeborah K Morrison
Jun 8, 2010·Nature Medicine·Nallasivam PalanisamyArul M Chinnaiyan
Jan 22, 2011·Nature Reviews. Molecular Cell Biology·Roi Avraham, Yosef Yarden
Feb 24, 2011·Journal of Medicinal Chemistry·Alexandra E GouldKatherine M Galvin
Apr 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul K PaikGregory J Riely
Jan 29, 2013·Molecular Cell·Alyson K FreemanDeborah K Morrison
May 21, 2013·Nature Chemical Biology·Hugo LavoieMarc Therrien
Oct 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Matthias DrostenMariano Barbacid

❮ Previous
Next ❯

Citations

Feb 20, 2016·Cellular and Molecular Life Sciences : CMLS·Fuquan Zhang, Jit Kong Cheong
Mar 22, 2016·Cancer Cell·Scott A FosterShiva Malek
Sep 17, 2015·Cancer Cell·Robert L Kortum, Deborah K Morrison
May 21, 2016·Frontiers in Cell and Developmental Biology·Claudia Wellbrock, Imanol Arozarena
Jun 10, 2016·Nature·Vanessa S Rodrik-OutmezguineKevan M Shokat
Oct 23, 2016·Cellular and Molecular Life Sciences : CMLS·David LakeJürgen Müller
Jun 24, 2016·British Journal of Cancer·Shivshankari Rajkumar, Ian R Watson
Sep 30, 2016·PloS One·Andrew M WatersJames L Hartley
Nov 12, 2016·Proceedings of the National Academy of Sciences of the United States of America·Ross A OkimotoTrever G Bivona
Nov 2, 2016·Pigment Cell & Melanoma Research·Edward J Hartsough, Michael J Vido
Mar 24, 2017·Expert Opinion on Therapeutic Targets·Beth K NeilsenKurt W Fisher
Feb 12, 2017·Molecular & Cellular Proteomics : MCP·Peter KubiniokPierre Thibault
Oct 27, 2017·Nature Reviews. Cancer·Julia Rotow, Trever G Bivona
Oct 7, 2017·Nature Reviews. Cancer·Zoi KarouliaPoulikos I Poulikakos
Jul 12, 2017·Molecular and Cellular Biology·Maho TakahashiPhilip J S Stork
Oct 27, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Y WangA Grothey
Nov 2, 2018·Biochemical Society Transactions·Soheila Rezaei AdarianiMohammad Reza Ahmadian
Jan 24, 2018·Cold Spring Harbor Perspectives in Medicine·Elizabeth M Terrell, Deborah K Morrison
Feb 27, 2019·Current Oncology Reports·Patrick R HallidayTrever G Bivona
Dec 14, 2017·British Journal of Cancer·David E Durrant, Deborah K Morrison
Jun 12, 2019·Cancers·Felix Behling, Jens Schittenhelm
Nov 28, 2017·Molecular Systems Biology·Benjamin M GyoriPeter K Sorger
Dec 20, 2017·Molecular Systems Biology·Rachel A Haggerty, Jeremy E Purvis
Oct 5, 2019·Cancers·Mehwish Khaliq, Mohammad Fallahi-Sichani
Jun 1, 2017·American Society of Clinical Oncology Educational Book·Melinda YushakRagini Kudchadkar
Oct 8, 2019·Genes, Chromosomes & Cancer·Danielle C Costigan, Fei Dong
Jan 17, 2020·Cells·Ufuk DegirmenciJiancheng Hu
Nov 22, 2017·The Oncologist·Kevin Shee, Todd W Miller
Sep 14, 2017·Molecular Diagnosis & Therapy·Sydney T Grob, Jean M Mulcahy Levy
May 21, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jenny Y Xue, Piro Lito
Jun 2, 2020·Cancer Medicine·Haotian LiuJilong Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.